Compare Price To Sales Ratio Across Equities
You can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible positions. Check out your portfolio center.
Cross Equities Price To Sales Ratio Analysis
Compare X4 Pharmaceuticals, Inozyme Pharma, and Acumen Pharmaceuticals Price To Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XFOR | 1.8255 | 1.8255 | 1.8255 | 1.8255 | 1.8255 | 1.8255 | 1.8255 | 1.8255 | 1.8255 | 43.0317 | 43.0317 | 43.0317 | 43.0317 | 38.73 | 40.66 |
| INZY | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ABOS | 476 | 476 | 476 | 476 | 476 | 476 | 476 | 476 | 476 | 476 | 562 | 562 | 562 | 506 | 415 |
| MREO | (101) | (101) | (101) | (101) | (101) | (101) | (101) | (101) | (1.8 K) | (1.8 K) | 2.3 K | 17.1116 | 248 | 152 | 101 |
| TERN | 179 | 179 | 179 | 179 | 179 | 179 | 179 | 179 | 179 | 179 | 179 | 179 | 179 | 161 | 143 |
| ELDN | 186 | 186 | 186 | 186 | 186 | 186 | 186 | 186 | 186 | 186 | 186 | 186 | 186 | 168 | 149 |
| HOOK | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 183 | 14.7708 | 4.155 | 3.7274 | 3.8038 | 3.61 |
| PDSB | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
X4 Pharmaceuticals, Inozyme Pharma, and Acumen Pharmaceuticals Price To Sales Ratio description
Price to Sales Ratio is figured by comparing entities stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on companies sales, a figure that is much harder to manipulate than other organizations multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Explore Investing Opportunities
You can quickly originate your optimal portfoio using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |